Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles

Glioblastoma is one of the most aggressive types of cancer with success of therapy being hampered by the existence of treatment resistant populations of stem-like Tumour Initiating Cells (TICs) and poor blood–brain barrier drug penetration. Therapies capable of effectively targeting the TIC populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lubanska, Dorota, Alrashed, Sami, Mason, Gage T., Nadeem, Fatima, Awada, Angela, DiPasquale, Mitchell, Sorge, Alexandra, Malik, Aleena, Kojic, Monika, Soliman, Mohamed A. R., deCarvalho, Ana C., Shamisa, Abdalla, Kulkarni, Swati, Marquardt, Drew, Porter, Lisa A., Rondeau-Gagné, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287456/
https://www.ncbi.nlm.nih.gov/pubmed/35840697
http://dx.doi.org/10.1038/s41598-022-15244-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287456/
https://www.ncbi.nlm.nih.gov/pubmed/35840697
http://dx.doi.org/10.1038/s41598-022-15244-0

Ejemplares similares